Recently, Morel et al. reported that the reduction of the expression of the glutamate transporter GLT1 in the end-stage SOD1 G93A mice, a mouse model of ALS, was a consequence of miR-124a activity. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.